Home / Anti-infectives / Emtricitabine, Tenofovir Disoproxil and Efavirenz
ATC J05AR06 · Antivirals for Systemic Use
Emtricitabine, Tenofovir Disoproxil and Efavirenz shortage
As of 31 Oct 2026, Emtricitabine, Tenofovir Disoproxil and Efavirenz has a reported shortage in 2 of the 5 countries we track (Italy, Belgium), covering 5 products.
Countries2/5
Products5packs or presentations
Short since5 Aug 20224.2 years ago
Earliest return31 Oct 2026company estimate
No return date2products
Main reasonOther
Timeline
ItalyBelgium
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | EFAVIRENZ / EMTRICITABINA / TENOFOVIR DISOPROXIL ZENTIVA | ZENTIVA K.S. | 5 Aug 2022 | not given | Increased demand Elevata richiesta: forniture discontinue |
| IT | EFAVIRENZ / EMTRICITABINA / TENOFOVIR DISOPROXIL MYLAN | MYLAN PHARMACEUTICALS LIMITED | 2 Dec 2024 | not given | Manufacturing problem Problemi produttivi |
| BE | Efavirenz/Emtricitabine/Tenofovir Disoproxil Krka 600 mg - 200 mg - 245 mg (Abacus Medicine) film-coat. tabl. 30 | KRKA d.d. Novo mesto | 10 Oct 2025 | 31 Oct 2026 | Other Other reason |
| BE | Efavirenz/Emtricitabine/Tenofovir Disoproxil Mylan 600 mg - 200 mg - 245 mg (Abacus Medicine) film-coat. tabl. 30 | Mylan Pharmaceuticals | 10 Oct 2025 | 31 Oct 2026 | Other Other reason |
| BE | Efavirenz/Emtricitabine/Tenofovir Disoproxil Mylan 600 mg - 200 mg - 245 mg (Abacus Medicine) film-coat. tabl. 90 (3 x 30) | Mylan Pharmaceuticals | 10 Oct 2025 | 31 Oct 2026 | Other Other reason |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.